International variation in chemotherapy use in cancer - Authors' reply.

Autor:	Barclay ME; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK., McPhail S; National Disease Registration Service, NHS England, Leeds, UK., Johnson SA; Cancer Intelligence, Cancer Research UK, London, UK., Swann R; National Disease Registration Service, NHS England, Leeds, UK; Cancer Intelligence, Cancer Research UK, London, UK., Lyratzopoulos G; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK; National Disease Registration Service, NHS England, Leeds, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.
Jazyk:	angličtina
Zdroj:	The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. e232.
DOI:	10.1016/S1470-2045(24)00275-4
Abstrakt:	Competing Interests: MEB reports personal fees from GRAIL Bio UK, for Independent Data Monitoring Committee membership unrelated to this study. GL declares research grant funding by the study sponsors to his employer (University College London). SM, SAJ, and RS declare no competing interests.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu